AUD 0.05
(1.89%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 239.76 Thousand AUD | 0.0% |
2023 | - AUD | -100.0% |
2022 | 98.45 Thousand AUD | 0.0% |
2021 | - AUD | 0.0% |
2020 | - AUD | 0.0% |
2019 | - AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 FY | 239.76 Thousand AUD | 0.0% |
2024 Q2 | 283.24 Thousand AUD | 0.0% |
2024 Q4 | 239.76 Thousand AUD | 0.0% |
2024 Q3 | 239.76 Thousand AUD | -15.35% |
2024 Q1 | 283.24 Thousand AUD | 0.0% |
2023 FY | - AUD | -100.0% |
2023 Q4 | - AUD | 0.0% |
2023 Q3 | - AUD | 0.0% |
2023 Q2 | - AUD | 0.0% |
2023 Q1 | - AUD | 100.0% |
2022 Q2 | - AUD | 0.0% |
2022 FY | 98.45 Thousand AUD | 0.0% |
2022 Q4 | -1.08 Million AUD | 0.0% |
2022 Q3 | - AUD | 0.0% |
2022 Q1 | - AUD | 0.0% |
2021 Q4 | - AUD | 0.0% |
2021 Q3 | - AUD | 0.0% |
2021 Q1 | - AUD | 0.0% |
2021 FY | - AUD | 0.0% |
2020 FY | - AUD | 0.0% |
2019 FY | - AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Mayne Pharma Group Limited | 74.62 Million AUD | 99.679% |